Adamax Liquid Spray

Ungraded: no published studies of Adamax exist in any form, so there is nothing to grade.

Strengths: 10 mg in 10 mL (1 mg/mL)
Contains: Adamax
Molecule: Undisclosed peptide described as a modified form of Semax
Mol. weight: 1032.3 g/mol (per the vial's COA)

Origin

The catalog describes Adamax as a modified form of Semax, the Russian nasal drug. Its chemical structure is not disclosed.

How it works

Unknown. There are no human or animal data on what it does or how it is absorbed. Nothing about Semax can be assumed for Adamax, which is a different, undisclosed molecule.

What the research shows

No studies of Adamax were found by any route. Plain Semax, its claimed parent, is used in Russia only as nasal drops, and FDA found no human pharmacokinetic data for Semax by any route. Absorption, effects and side effects of Adamax are all unknown.

Safety findings

No toxicology, allergy or pharmacokinetic data exist for the molecule. The liquid's carrier and preservative are not disclosed, so ingredient sensitivities and how long an opened bottle stays clean cannot be judged.

Regulatory status

Not FDA-approved. Not on FDA's 503A nominations list or safety-risk list, so not lawfully compoundable. Not named by WADA; likely S0 (non-approved substance).

Catalog notes

Offered as 10 mg in 10 mL. No certificate is published yet for the spray, and the carrier, pH, preservative, sequence, purity specification and after-opening shelf life are not listed. Follow the storage stated on the label and certificate. The 10 mg powder vial has a certificate (COA7596).